https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=31245092&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 3124509220220331
2072-143911Suppl 92019MayJournal of thoracic diseaseJ Thorac DisDissection of the left paratracheal area is frequently missed during left side non-small cell lung cancer surgery.S1226S1228S1226-S122810.21037/jtd.2019.03.15VarelaGonzaloGSalamanca Institute of Biomedical Research (IBSAL), Salamanca, Spain.JiménezMarcelo FMFThoracic Surgery Service, Salamanca University Hospital, Salamanca, Spain.engEditorialComment
ChinaJ Thorac Dis1015339162072-1439J Thorac Dis. 2018 Dec;10(12):6458-6465. doi: 10.21037/jtd.2018.11.8630746188Conflicts of Interest: The authors have no conflicts of interest to declare.
201962860201962860201962861201951ppublish31245092PMC656054710.21037/jtd.2019.03.15jtd-11-S9-S1226Shibano T, Tsubochi H, Tetsuka K, et al. Left mediastinal node dissection after arterial ligament transection via video-assisted thoracoscopic surgery for potentially advanced stage I non-small cell lung cancer. J Thorac Dis 2018;10:6458-65. 10.21037/jtd.2018.11.8610.21037/jtd.2018.11.86PMC634470330746188Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-92. 10.1016/j.ejcts.2006.08.00810.1016/j.ejcts.2006.08.00816971134Sakao Y, Miyamoto H, Yamazaki A, et al. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy. Eur J Cardiothorac Surg 2006;30:543-7. 10.1016/j.ejcts.2006.05.02410.1016/j.ejcts.2006.05.02416870462Yang MZ, Hou X, Liang RB, et al. The incidence and distribution of mediastinal lymph node metastasis and its impact on survival in patients with non-small-cell lung cancers 3 cm or less: data from 2292 cases. Eur J Cardiothorac Surg 2019. [Epub ahead of print].30668665Shien K, Toyooka S, Soh J, et al. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division. Interact Cardiovasc Thorac Surg 2015;20:791-6. 10.1093/icvts/ivv06210.1093/icvts/ivv06225805399Maeda R, Suda T, Hachimaru A, et al. Clinical significance of preoperative carcinoembryonic antigen level in patients with clinical stage IA non-small cell lung cancer. J Thorac Dis 2017;9:176-86. 10.21037/jtd.2017.01.3010.21037/jtd.2017.01.30PMC530308228203421Lin JT, Yang XN, Zhong WZ, et al. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer. Eur J Cardiothorac Surg 2016;50:914-9. 10.1093/ejcts/ezw10910.1093/ejcts/ezw10927113090Maeda R, Isowa N, Onuma H, et al. The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer. Interact Cardiovasc Thorac Surg 2009;9:79-82. 10.1510/icvts.2008.20125110.1510/icvts.2008.20125119366724Zhao F, Zhou Y, Ge PF, et al. A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer. BMC Cancer 2017;17:267. 10.1186/s12885-017-3273-x10.1186/s12885-017-3273-xPMC539038328407802Yu X, Li Y, Shi C, et al. Risk factors of lymph node metastasis in patients with non-small cell lung cancer ≤ 2 cm in size: A monocentric population-based analysis. Thorac Cancer 2018;9:3-9. 10.1111/1759-7714.1249010.1111/1759-7714.12490PMC575429729034994Wang L, Jiang W, Zhan C, et al. Lymph node metastasis in clinical stage IA peripheral lung cancer. Lung Cancer 2015;90:41-6. 10.1016/j.lungcan.2015.07.00310.1016/j.lungcan.2015.07.00326212683Bao F, Yuan P, Yuan X, et al. Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer. J Thorac Dis 2014;6:1697-703.PMC428333825589962Herth FJ. Nonsurgical staging of the mediastinum: EBUS and EUS. Semin Respir Crit Care Med 2011;32:62-8. 10.1055/s-0031-127287010.1055/s-0031-127287021500125Um SW, Kim HK, Jung SH, et al. Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol 2015;10:331-7. 10.1097/JTO.000000000000038810.1097/JTO.000000000000038825611227Jeebun V, Harrison RN. Understanding local performance data for EBUS-TBNA: insights from an unselected case series at a high volume UK center. J Thorac Dis 2017;9:S350-62. 10.21037/jtd.2017.05.1810.21037/jtd.2017.05.18PMC545986928603645Koike T, Koike T, Yamato Y, et al. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J Thorac Oncol 2012;7:1246-51. 10.1097/JTO.0b013e31825871de10.1097/JTO.0b013e31825871de22659962NSCLC Meta-analysis Collaborative Group Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet 2014;383:1561-71. 10.1016/S0140-6736(13)62159-510.1016/S0140-6736(13)62159-5PMC402298924576776Lim E, Harris G, Patel A, et al. Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials. J Thorac Oncol 2009;4:1380-8. 10.1097/JTO.0b013e3181b9ecca10.1097/JTO.0b013e3181b9ecca19861907Lim E, McElnay PJ, Rocco G, et al. Invasive mediastinal staging is irrelevant for PET/CT positive N2 lung cancer if the primary tumour and ipsilateral lymph nodes are resectable. Lancet Respir Med 2015;3:e32-3. 10.1016/S2213-2600(15)00321-510.1016/S2213-2600(15)00321-526380888